Annual Report — Form 10-K
Filing Table of Contents
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 747K
2: EX-10.15 Material Contract 62 229K
3: EX-10.17 Material Contract 2 13K
4: EX-10.18 Material Contract 2 13K
5: EX-10.19 Material Contract 3 17K
6: EX-10.20 Material Contract 2 14K
7: EX-10.21 Material Contract 7 30K
8: EX-10.32 Material Contract 5 16K
9: EX-10.33 Material Contract 5 18K
10: EX-10.34 Material Contract 4 13K
11: EX-10.35 Material Contract 4 13K
12: EX-21.1 Subsidiaries of the Registrant 2± 9K
13: EX-23.1 Consent of Experts or Counsel 1 9K
14: EX-31.1 Certification per Sarbanes-Oxley Act (Section 302) 2 12K
15: EX-31.2 Certification per Sarbanes-Oxley Act (Section 302) 2 11K
16: EX-32.1 Certification per Sarbanes-Oxley Act (Section 906) 1 9K
EX-10.34 — Material Contract
| EX-10.34 | 1st Page of 4 | TOC | ↑Top | Previous | Next | ↓Bottom | Just 1st |
|---|
Exhibit 10.34
NONQUALIFIED
STOCK OPTION AGREEMENT UNDER
THE________________________ PLAN
OF
CRAY INC.
[Date]
[Name and Address]
Dear __________:
Cray Inc. (the "Company") has granted you an option to purchase the shares of
the Company's Common Stock specified below. This option is granted pursuant to
the Company's_______ Plan (the "Plan"), the terms of which are incorporated
herein by this reference. All terms defined in the Plan and not defined herein
have the respective meanings provided in the Plan.
For a detailed explanation of the option you have been granted, you are referred
to the Plan. Without limiting the specificity of the terms as set forth in the
Plan, the following summarizes some of the most important of the terms set forth
in the Plan and certain other terms and conditions pursuant to which this option
is granted and may be exercised:
Number of Shares: You may purchase up to a total of __________shares of the
Company's Common Stock pursuant to this option.*
Exercise Price: $ _________ per share*
Date Option Granted: [Date]
---------------
*These figures are subject to change in certain situations described in Section
8 of the Plan.
1
Term of This Option: Unless sooner terminated, this option must be exercised on
or before ten years from the date of grant.
Exercise Schedule: This option shall vest and become exercisable on a monthly
basis so that 1/12th of the option shall vest on the 12th day of each month,
beginning on [Date], and the option shall be fully exercisable on [Date].
If you cease being a director before this options vests in whole for any reason
other than disability or death, then the vesting of this option shall stop as of
the date that you cease being a director. If you cease being a director due to
disability or death, then all of this option shall then become vested in full as
of such event. Termination of this option is described below.
How to Exercise. To exercise this option in whole or in part (usually, a minimum
of 100 shares) at least one full business day prior to the date you wish to
exercise the option you must deliver to the Company a written notice of exercise
and the exercise price, in cash or by check, for the number of shares you desire
to purchase. You also may pay through irrevocable instructions to a stock broker
to deliver the amount of sales proceeds necessary to pay the exercise price in
accordance with applicable governmental regulations. You also must execute such
other documents as the Company may request. You should contact the Company in
advance when you are considering an exercise of this option.
Termination of Option: This option shall not terminate for the reasons described
in Sections 5.5.1 through 5.5.4 of the Plan, but shall terminate pursuant to
Section 5.5.5 of the Plan.
No Transfer of Option: This option cannot be transferred except by will or the
applicable laws of descent and distribution.
Non-Qualified Stock Option: This option is not intended to be an "Incentive
Stock Option," as that term is defined in Section 422 of the Internal Revenue
Code, as amended. At the time you exercise this option, there will be certain
tax consequences. You should seek tax advice in this regard.
Please execute the attached letter indicating whether you choose to accept or
decline this option upon the terms set forth in the Plan and above, and return
the letter to the Company.
Very truly yours,
CRAY INC.
By: ___________________________________
James E. Rottsolk, Chairman and Chief
Executive Officer
2
ELECTION TO ACCEPT OR DECLINE STOCK OPTION
I ____ ACCEPT ____ DECLINE the Nonqualified Stock Option granted to
me pursuant to the______ Plan of Cray Inc. (the "Plan") and as set forth in this
option agreement. If I accept the grant of the option, I acknowledge that I have
received and understood, and agree to, the terms of this option agreement and
the Plan.
DATED:__________________________________
__________________________________
3
Notice of Exercise of Nonqualified Stock Option
To: CRAY INC.
I hereby exercise my nonqualified stock option granted by Cray Inc. (the
"Company") on ___________________, subject to all the terms and provisions
thereof and of the _____________ Plan referred to therein, and notify the
Company of my desire to purchase ______________of $________ per share , or an
aggregate exercise price of $________________.
I hereby deliver the full exercise price and if any) all applicable
withholding taxes with respect to this exercise as follows:
_______________ cash
_______________ bank certified or cashier's check, or
_______________ irrevocable instructions to a stock broker to
deliver the necessary sales proceeds, all in
accordance with applicable governmental
regulations.
_______________ the Company should withhold shares with a
fair market value equal to the withholding
tax obligation.
I further agree to execute such other documents as the Company may
request.
Date:___________________________________________
Signature:______________________________________
Print Name:_____________________________________
Address:________________________________________
4
↑Top
Filing Submission 0000891020-05-000085 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help —
Sun., Apr. 28, 1:06:03.1am ET 